Lantibiotics

Oragenics to Participate in Two Investment Conferences During March

Retrieved on: 
Monday, March 8, 2021
Infectious diseases, Pharmaceutical, Health, Medical specialties, Health sciences, Health, Animal virology, Coronavirus, Lantibiotics, Vaccine

Institutional and other investors interested in scheduling a one-on-one meeting with Oragenics during any of these conferences should contact their sales representative at the sponsoring investment bank.

Key Points: 
  • Institutional and other investors interested in scheduling a one-on-one meeting with Oragenics during any of these conferences should contact their sales representative at the sponsoring investment bank.
  • Oragenics, Inc. is focused on the creation of the Terra CoV-2 development of effective treatments for novel antibiotics against infectious disease.
  • The Company is dedicated to the development and commercialization of a vaccine candidate providing specific immunity from novel coronavirus.
  • In addition, Oragenics has an exclusive worldwide channel collaboration with ILH Holdings, Inc. (n/k/a Eleszto Genetika, Inc.), relating to the development of novel lantibiotics.

Global Nisin Market Size, Share, COVID Impact Analysis and Forecast Report 2021-2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 23, 2021
Retail, Chemicals, Plastics, Manufacturing, Food, Beverage, Peripheral membrane proteins, Lantibiotics, Nisin, Preservatives, Impact of the COVID-19 pandemic, Branches of biology

The "2021 Nisin Market - Size, Share, COVID Impact Analysis and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2021 Nisin Market - Size, Share, COVID Impact Analysis and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • 2021 Nisin Market - Size, Share, COVID Impact Analysis and Forecast to 2027 - is comprehensive research with in-depth data and contemporary analysis of Nisin Market at a global, regional and key country level, split by different sub-segments of the industry.
  • Nisin Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations.
  • Global Nisin Market Industry size, 2020-2027
    Nisin applications and end-user verticals market size, 2020-2027
    Nisin Market size across countries, 2020-2027
    5 leading companies in the industry - overview, key strategies, financials, and products

Nisin Market by Application and Region - Global Trends and Forecast to 2025

Retrieved on: 
Thursday, July 2, 2020
Articles, Food and drink, Lantibiotics, Food industry, Peripheral membrane proteins, Diets, Climate change mitigation, Ethical theories, Nisin, Vegetarianism, Meat, Food

8.1.1 Covid-19 Impact on Nisin Market, by Application

Key Points: 
  • 8.1.1 Covid-19 Impact on Nisin Market, by Application
    8.3.1 Meat, Poultry & Seafood Products Are Prone to Spore and Mold Infections, and Therefore, Are Profitable Markets for Nisin
    9.2.1.1 Increase in Consumption of Vegetarian Food Products to Drive the Growth of the Dairy Market in the US, Which, in Turn, Encourages the Demand for Nisin
    9.3.1.1 Increase in Consumption of Beverages Encourages the Growth of the Dairy Market in Germany, Driving the Demand for Nisin
    9.4.3.1 Change in the Lifestyle of Consumers Has Led to An Increase in Demand for Clean Label Products, Driving the Growth of the Market

Nisin Market Worth $553 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, June 16, 2020
Articles, Branches of biology, Food preservation, Nature, Peripheral membrane proteins, Lantibiotics, Biopreservation, Microbiology, Nisin, Recycling, Sterilization, Sustainability

The increase in awareness toward environmental sustainability and recyclable properties of nisin are factors driving the growth of the nisin industry.

Key Points: 
  • The increase in awareness toward environmental sustainability and recyclable properties of nisin are factors driving the growth of the nisin industry.
  • The use of nisin has positive, economic, and ecologic effects, such as the reduction in damaged sterilization products and less processing times and temperatures.
  • Therefore, manufacturers prefer investing in nisin as a biopreservative for dairy products, thereby encouraging the demand for this application segment.
  • Key manufacturers of nisin are based in Asia Pacific and are focusing on gaining a major market share.

Nisin Market Worth $553 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, June 16, 2020
Articles, Branches of biology, Food preservation, Nature, Peripheral membrane proteins, Lantibiotics, Biopreservation, Microbiology, Nisin, Recycling, Sterilization, Sustainability

The increase in awareness toward environmental sustainability and recyclable properties of nisin are factors driving the growth of the nisin industry.

Key Points: 
  • The increase in awareness toward environmental sustainability and recyclable properties of nisin are factors driving the growth of the nisin industry.
  • The use of nisin has positive, economic, and ecologic effects, such as the reduction in damaged sterilization products and less processing times and temperatures.
  • Therefore, manufacturers prefer investing in nisin as a biopreservative for dairy products, thereby encouraging the demand for this application segment.
  • Key manufacturers of nisin are based in Asia Pacific and are focusing on gaining a major market share.

Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog

Retrieved on: 
Friday, November 15, 2019
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious diseases, Other Health, Articles, Health, Branches of biology, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Lantibiotics, Lanthionine, Antibiotic, Antimicrobial resistance, Brilacidin, Lantibiotics, Oragenics, Inc.

The study, titled Complete synthesis of the bicyclic ring of a mutacin analog with orthogonally protected lanthionine via solid-phase intracyclization was published in the recent issue (volume 25, Issue 11) of Journal of Peptide Science.

Key Points: 
  • The study, titled Complete synthesis of the bicyclic ring of a mutacin analog with orthogonally protected lanthionine via solid-phase intracyclization was published in the recent issue (volume 25, Issue 11) of Journal of Peptide Science.
  • Lantibiotics are a class of antibiotic compounds with a novel mechanism of action, prized for their ability to overcome antibiotic-resistant infections.
  • With resistant strains on the rise, particularly healthcare-acquired infections (HAI), the need for these potent lantibiotic agents is critical.
  • We are focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis.

Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications

Retrieved on: 
Monday, November 11, 2019
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious diseases, Articles, Health, Lantibiotics, Branches of biology, Antibiotic, Antimicrobial resistance, Lantibiotics, Oragenics, Inc.

The International Conference on Microbial Research and Applications will be held November 13-14, 2019 at the Radisson Hotel, Downton-Inner Harbor in Baltimore, Md.

Key Points: 
  • The International Conference on Microbial Research and Applications will be held November 13-14, 2019 at the Radisson Hotel, Downton-Inner Harbor in Baltimore, Md.
  • Dr. Handfields talk will be titled, Lantibiotics: a large untapped pipeline of attractive scaffolds for the development of novel antibiotics.
  • Those interested in attending the talk may register for the conference via its website, https://unitedscientificgroup.com/conferences/microbiology-research/ .
  • Lantibiotics are a class of antibiotic compounds with novel mechanism of action, prized for their ability to overcome antibiotic-resistant infections.

Oragenics, Inc. to Present at the BIO Investor Forum

Retrieved on: 
Tuesday, October 22, 2019
Infectious diseases, Pharmaceutical, Health, Oncology, Articles, Health, Intrexon, Lantibiotics, Antimicrobial resistance, Branches of biology, Antibiotic, AG013, Lantibiotics, Oragenics, Inc.

The company will present to investors on October 23, 2019, at 2:30 PM ET in the Yorkshire Room of Westin St. Francis in San Francisco.

Key Points: 
  • The company will present to investors on October 23, 2019, at 2:30 PM ET in the Yorkshire Room of Westin St. Francis in San Francisco.
  • The BIO Investor Forum will be held October 22-23, 2019.
  • The compound was designed by the companys strategic partner, ActoBio Therapeutics, Inc., a wholly-owned subsidiary of Intrexon Corporation (NYSE: XON).
  • Lantibiotics are a class of antibiotic compounds with novel mechanism of action, prized for their ability to overcome antibiotic-resistant infections.

Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium

Retrieved on: 
Tuesday, August 20, 2019
General Health, Health, Pharmaceutical, Clinical trials, Florida, Gaylord Hotels, Gaylord Palms Resort & Convention Center, Kissimmee, Florida, Symposium, Military medicine, MHSRS, Lantibiotics, Oragenics, Inc.

This talk will be presented on Thursday, August 22, 2019 at 8:30 AM ET at the annual Military Health System Research Symposium (MHSRS) held this year at the Gaylord Palms Resort & Convention Center, Kissimmee Fla.

Key Points: 
  • This talk will be presented on Thursday, August 22, 2019 at 8:30 AM ET at the annual Military Health System Research Symposium (MHSRS) held this year at the Gaylord Palms Resort & Convention Center, Kissimmee Fla.
  • The symposium is sponsored by the United States Department of Defense and is an invitation-only event for presenters.
  • We look forward to sharing our data with this audience and discussing the implications for use in both military and civilian settings.
  • The MHSRS is the only military or civilian meeting that focuses specifically on the unique medical needs of the Warfighter.

Nisin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2028

Retrieved on: 
Wednesday, July 17, 2019
Peripheral membrane proteins, Lantibiotics, Nisin, Preservatives, Branches of biology

This in-depth report also analyzes the key indicators associated with the nisin market during the foreseeable timeframe.An in-depth study on the supply chain of the nisin market is also included in this research report.

Key Points: 
  • This in-depth report also analyzes the key indicators associated with the nisin market during the foreseeable timeframe.An in-depth study on the supply chain of the nisin market is also included in this research report.
  • The report also delivers Y-o-Y growth comparison, market share comparison, and volume and revenue comparison for readers to have a thorough understanding of the nisin market.
  • Some of the key questions answered in this report include:
    What will be the size of the nisin market in 2022?
  • In addition to this, primary and secondary research has been undertaken to cull actionable intelligence on the behavior of the nisin market.